Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Junmei Chen, Jinman Liu, Yueyue Huang, Ruoyu Li, Cuiru Ma, Beiping Zhang, Fanchang Wu, Wenqian Yu, Xue Zuo, Yong Liang & Qi Wang. (2021) Insights into oral bioavailability enhancement of therapeutic herbal constituents by cytochrome P450 3A inhibition. Drug Metabolism Reviews 53:4, pages 491-507.
Read now
Read now
Ahmed A. El-Sherbeni & Ayman O. S. El-Kadi. (2017) Microsomal cytochrome P450 as a target for drug discovery and repurposing. Drug Metabolism Reviews 49:1, pages 1-17.
Read now
Read now
P. Aracena, C. Lazo-Hernández, A. Molina-Berríos, D. R. Sepúlveda, C. Reinoso, J. I. Larraín, J. Navarro & M. E. Letelier. (2014) Microsomal oxidative stress induced by NADPH is inhibited by nitrofurantoin redox biotranformation. Free Radical Research 48:2, pages 129-136.
Read now
Read now
Miyoung Yoon, Jerry L. Campbell, Melvin E. Andersen & Harvey J. Clewell. (2012) Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results. Critical Reviews in Toxicology 42:8, pages 633-652.
Read now
Read now
K. Youdim & R. Dodia. (2010) Comparison between recombinant P450s and human liver microsomes in the determination of cytochrome P450 Michaelis–Menten constants. Xenobiotica 40:4, pages 235-244.
Read now
Read now
Articles from other publishers (15)
Katarína Vavrová, Radek Indra, Petr Pompach, Zbyněk Heger & Petr Hodek. (2022) The impact of individual human cytochrome P450 enzymes on oxidative metabolism of anticancer drug lenvatinib. Biomedicine & Pharmacotherapy 145, pages 112391.
Crossref
Crossref
Ying Jiang, Zichao Yang, Lishun Zhang, Ruohong Yan, Siming Liu, Haikui Yang, Shanhe Wan, Zhonghuang Li, Zhengguang Zhu, Ling Ye & Jiajie Zhang. (2020) The cytochrome P450 metabolic profiling of SMU-B in vitro, a novel small molecule tyrosine kinase inhibitor. Journal of Pharmaceutical and Biomedical Analysis 188, pages 113400.
Crossref
Crossref
Hannu Raunio, Olli Pentikäinen & Risto O. Juvonen. (2020) Coumarin-Based Profluorescent and Fluorescent Substrates for Determining Xenobiotic-Metabolizing Enzyme Activities In Vitro. International Journal of Molecular Sciences 21:13, pages 4708.
Crossref
Crossref
Patrick C. F. Buchholz, Rüdiger Ohs, Antje C. Spiess & Jürgen Pleiss. (2019) Progress Curve Analysis Within BioCatNet: Comparing Kinetic Models for Enzyme-Catalyzed Self-Ligation. Biotechnology Journal 14:3, pages 1800183.
Crossref
Crossref
Marie Stiborová, Radek Indra, Michaela Moserová, Lucie Bořek-Dohalská, Petr Hodek, Eva Frei, Klaus Kopka, Heinz H. Schmeiser & Volker M. Arlt. (2017) Comparison of human cytochrome P450 1A1-catalysed oxidation of benzo[a]pyrene in prokaryotic and eukaryotic expression systems. Monatshefte für Chemie - Chemical Monthly 148:11, pages 1959-1969.
Crossref
Crossref
T. Bohnert, A. Patel, I. Templeton, Y. Chen, C. Lu, G. Lai, L. Leung, S. Tse, H. J. Einolf, Y.-H. Wang, M. Sinz, R. Stearns, R. Walsky, W. Geng, S. Sudsakorn, D. Moore, L. He, J. Wahlstrom, J. Keirns, R. Narayanan, D. Lang & X. Yang. (2016) Evaluation of a New Molecular Entity as a Victim of Metabolic Drug-Drug Interactions--an Industry Perspective. Drug Metabolism and Disposition 44:8, pages 1399-1423.
Crossref
Crossref
Ahmed A. El-Sherbeni & Ayman O. S. El-Kadi. (2016) Repurposing Resveratrol and Fluconazole To Modulate Human Cytochrome P450-Mediated Arachidonic Acid Metabolism. Molecular Pharmaceutics 13:4, pages 1278-1288.
Crossref
Crossref
Sharad S. Singhal, Jyotsana Singhal, James Figarola, David Horne & Sanjay Awasthi. (2015) RLIP76 Targeted Therapy for Kidney Cancer. Pharmaceutical Research 32:10, pages 3123-3136.
Crossref
Crossref
Ahmed A. El-Sherbeni & Ayman O.S. El-Kadi. (2014) Characterization of Arachidonic Acid Metabolism by Rat Cytochrome P450 Enzymes: The Involvement of CYP1As. Drug Metabolism and Disposition 42:9, pages 1498-1507.
Crossref
Crossref
Paul M. van Midwoud, Marjolijn T. Merema, Niek Verweij, Geny M.M. Groothuis & Elisabeth Verpoorte. (2011) Hydrogel embedding of precision-cut liver slices in a microfluidic device improves drug metabolic activity. Biotechnology and Bioengineering 108:6, pages 1404-1412.
Crossref
Crossref
W. Griffith Humphreys. 2011. Mass Spectrometry in Drug Metabolism and Disposition. Mass Spectrometry in Drug Metabolism and Disposition
229
253
.
Paul M. van Midwoud, Elisabeth Verpoorte & Geny M. M. Groothuis. (2011) Microfluidic devices for in vitro studies on liver drug metabolism and toxicity. Integrative Biology 3:5, pages 509.
Crossref
Crossref
Sean C Gay, Arthur G Roberts & James R Halpert. (2010) Structural features of cytochromes P450 and ligands that affect drug metabolism as revealed by x-ray crystallography and NMR. Future Medicinal Chemistry 2:9, pages 1451-1468.
Crossref
Crossref
Tonika Bohnert & Liang‐Shang Gan. 2009. Enzyme Inhibition in Drug Discovery and Development. Enzyme Inhibition in Drug Discovery and Development
91
176
.
Jae H. Chang, Phillip Yoo, Theresa Lee, Wendy Klopf & Denise Takao. (2009) The Role of pH in the Glucuronidation of Raloxifene, Mycophenolic Acid and Ezetimibe. Molecular Pharmaceutics 6:4, pages 1216-1227.
Crossref
Crossref